GUYER WILLIAM (Chief Development Officer) sold 48.1% of their position (3.70K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $418.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/6/2026ACC: 0001193125-26-338637
Officer· Chief Development Officer
Since Aug 2021
-3.70K
Net shares
Net seller
$418.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.70K acquired · 7.40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.70K
Price / share
$21.65
Trade value
$80.11K
% of position
92.8%
8/4/2026
3.98K→7.68K
Common Stock
Direct
Shares
−3.70K
Price / share
$113.12
Trade value
$418.56K
% of position
48.1%
8/4/2026
7.68K→3.98K
Total
Net shares
+0.00
Net value
-$338.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/4/2026 | M · Option Exercise | +3.70K | $21.65 | $80.11K | 92.8% | 3.98K | 7.68K |
| Common Stock Direct | 8/4/2026 | S · Sale | −3.70K | $113.12 | $418.56K | 48.1% | 7.68K | 3.98K |
| Total | +0.00 | -$338.46K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
3.70K shares
Shares
−3.70K
Strike price
21.65
Held after
126.30K
Exercisable
—
8/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.70K shares | 8/4/2026 | M · Option Exercise | −3.70K | 21.65 | — | 126.30K |